Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA

OnabotulinumtoxinA is one of the main preventive treatments for chronic migraine. Despite that up to one third of patients with chronic migraine suffer from daily headache, these individuals have hardly been studied. We conducted a prospective cohort study, including patients with chronic migraine a...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Pías, Enrique, Guerrero, Ángel L., Sierra, Álvaro, Trigo, Javier, García-Azorín, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234385/
https://www.ncbi.nlm.nih.gov/pubmed/34205832
http://dx.doi.org/10.3390/toxins13060432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234385/
https://www.ncbi.nlm.nih.gov/pubmed/34205832
http://dx.doi.org/10.3390/toxins13060432

Ejemplares similares